http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107033037-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C303-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-40
filingDate 2017-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107033037-B
titleOfInvention A kind of method of asymmetric synthesis by chiral acid catalyzed optical voidness terpenoid alkaloid analog
abstract The invention discloses a kind of methods for preparing optical voidness terpenoid alkaloid analog, this method is using aldehyde, p-methylphenyl sulphonylamine as raw material, chiral phosphamide (CPA) is used as catalyst, Magnesium Thiosulfate Hexahydrate is as additive, reaction obtains optical voidness terpenoid alkaloid analog at 0 to -60 DEG C, and reaction equation is (1).The present invention realize it is a kind of by chiral phosphamide be catalyzed polyenoid cyclization come the method for preparing optical voidness terpenoid alkaloid analog, this method is succinctly feasible, and application prospect is extensive.
priorityDate 2017-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454507067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419576745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423525048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24193011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54603520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455585947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426352447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10955174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55250308
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448249708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344

Total number of triples: 43.